176
Views
22
CrossRef citations to date
0
Altmetric
Original Article

The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma

, , , , &
Pages 879-894 | Accepted 11 Jan 2008, Published online: 08 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Naimat Khan, Jørgen Vestbo, Adam Garrow, Pradeep Karur, Umme Kolsum, Sarah Tyson, Dave Singh & Janelle Yorke. (2018) The Manchester Respiratory-related Sleep Symptoms scale for patients with COPD: development and validation. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3885-3894.
Read now
Roslina Abdul Manap, Li Cher Loh, Tengku Saifudin Tengku Ismail, Abdul Razak Muttalif, George Kutty Simon, Rosalind Beng Hong Toh, Mohd Razali Norhaya, Noor Aliza Md Tarekh, Che Wan Aminuddin Hashim, Mohammad Fauzi Abdul Rani & Aziah Ahmad Mahayiddin. (2012) Satisfaction levels and asthma control amongst Malaysian asthmatic patients on budesonide/formoterol maintenance and reliever therapy: experience in a real-life setting. Patient Related Outcome Measures 3, pages 71-78.
Read now
Sheldon L. Spector, Ubaldo J. Martin, Tom Uryniak & Christopher D. O'Brien. (2012) Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma. Journal of Asthma 49:1, pages 70-77.
Read now
Nashmia Qamar, Andrea A Pappalardo, Vineet M Arora & Valerie G Press. (2011) Patient-centered care and its effect on outcomes in the treatment of asthma. Patient Related Outcome Measures 2, pages 81-109.
Read now

Articles from other publishers (14)

Jessica Castner, Carla R. Jungquist, Manoj J. Mammen, John J. Pender, Olivia Licata & Sanjay Sethi. (2020) Prediction model development of women's daily asthma control using fitness tracker sleep disruption. Heart & Lung 49:5, pages 548-555.
Crossref
Aniruddha Mukhopadhyay, Mirna Waked, Jaideep Gogtay & Vaibhav Gaur. (2020) Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma. Respiratory Medicine 170, pages 106055.
Crossref
Sadia Janjua, Stefanie Schmidt, Montse Ferrer & Christopher J Cates. (2019) Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
F. Sundbom, E. Lindberg, A. Bjerg, B. Forsberg, K. Franklin, M. Gunnbjörnsdottir, R. Middelveld, K. Torén & C. Janson. (2012) Asthma symptoms and nasal congestion as independent risk factors for insomnia in a general population: results from the GA 2 LEN survey . Allergy 68:2, pages 213-219.
Crossref
James Zangrilli, Lyndon E. Mansfield, Tom Uryniak & Christopher D. O'Brien. (2011) Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. Annals of Allergy, Asthma & Immunology 107:3, pages 258-265.e2.
Crossref
Nemr S. EidMichael J. NoonanBradley Chipps, Bhash Parasuraman, Christopher J. Miller & Christopher D. O'Brien. (2010) Once- vs Twice-Daily Budesonide/Formoterol in 6- to 15-Year-Old Patients With Stable Asthma. Pediatrics 126:3, pages e565-e575.
Crossref
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. (2010) Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Evidence-Based Child Health: A Cochrane Review Journal 5:3, pages 1456-1542.
Crossref
Harold Nelson, Catherine Bonuccelli, Finn Radner, Anders Ottosson, Kevin J. Carroll, Tomas L.G. Andersson & Craig LaForce. (2010) Safety of formoterol in patients with asthma: Combined analysis of data from double-blind, randomized controlled trials. Journal of Allergy and Clinical Immunology 125:2, pages 390-396.e8.
Crossref
Mohammad Hamzavi. (2010) Combination Therapy with Budesonide and Formoterol in Single Inhaler of Asthma. Clinical Medicine Insights: Therapeutics 2, pages 1179559X1000200.
Crossref
&NA;. (2009) Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma. Drugs & Therapy Perspectives 25:11, pages 1-4.
Crossref
Edward M. Kerwin, John J. Oppenheimer, Craig LaForce, Bhash Parasuraman, Christopher J. Miller, Liza O’Dowd & Mitchell Goldman. (2009) Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/formoterol dosing. Annals of Allergy, Asthma & Immunology 103:1, pages 62-72.
Crossref
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Paul Chervinsky, James Baker, George Bensch, Bhash Parasuraman, Robert Boggs, Paula Martin & Liza O’Dowd. (2008) Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Annals of Allergy, Asthma & Immunology 101:5, pages 463-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.